Evidence map›Paper›PMID 38587703›Full record

ArticleJournal of clinical immunology2024

Novel Synonymous Variant in IL7R Causes Preferential Expression of the Soluble Isoform.

Rafah Mackeh, Yasmin El Bsat, Asha Elmi, Hani Bibawi, Mohammed Yousuf Karim, Amel Hassan, Bernice Lo

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rafah Mackeh *Research Branch, Sidra Medicine, Doha, Qatar.ORCID 0000-0003-3648-2198
Yasmin El Bsat *Research Branch, Sidra Medicine, Doha, Qatar.
Asha ElmiResearch Branch, Sidra Medicine, Doha, Qatar.
Hani BibawiDivision of Hematopathology, Sidra Medicine, Doha, Qatar.
Mohammed Yousuf KarimDivision of Hematopathology, Sidra Medicine, Doha, Qatar.
Amel HassanPediatric Allergy and Immunology Department, Sidra Medicine, Ar-Rayyan, Qatar.
Bernice LoResearch Branch, Sidra Medicine, Doha, Qatar. blo@sidra.org.
Qatar Airways (Qatar) · QAQatar University · QA

Funding

Qatar National Research Fund PPM-04-0128-200015
6 · The paper itself

Abstract

purposeThe interleukin-7 receptor (IL-7R) is primarily expressed on lymphoid cells and plays a crucial role in the development, proliferation, and survival of T cells. Autosomal recessive mutations that disrupt IL-7Rα chain expression give rise to a severe combined immunodeficiency (SCID), which is characterized by lymphopenia and a T

methodsWhole genome sequencing (WGS) was utilized to identify potential variants causing the SCID phenotype. Splicing prediction tools were employed to assess the deleterious impact of the mutation. Polymerase Chain Reaction (PCR), Sanger sequencing, flow cytometry, and ELISA were then used to validate the pathogenicity of the detected mutation.

resultsWe discovered a novel homozygous synonymous mutation in the IL7R gene. Our functional studies indicate that this variant is pathogenic, causing exon 6, which encodes the transmembrane domain, to be preferentially spliced out.

conclusionIn this study, we identified a novel rare synonymous mutation causing a loss of IL-7Rα expression at the cellular membrane. This case demonstrates the value of reanalyzing genetic data based on the clinical phenotype and highlights the significance of functional studies in determining the pathogenicity of genetic variants.

Indexed as

Interleukin-7 Receptor alpha SubunitSilent MutationEnzyme-Linked Immunosorbent AssayExonsFlow CytometryHumansMutationIL7R protein, humanInterleukin-7 Receptor alpha SubunitAltered splicingIL-7Rα deficiencyIL-7Rα exon 6Primary immunodeficiency (PID)Severe Combined Immunodeficiency (SCID)Synonymous variant

Identifiers

PMID38587703
PMCPMC11001715
OpenAlexW4394576861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.